This survey examines surgeons’ knowledge of contralateral prophylactic mastectomy.
This study examines the temporal trends in and the factors associated with contralateral prophylactic mastectomy among men who received a diagnosis of unilateral invasive breast cancer.
This cohort study evaluates the impact of extranodal extension size on axillary nodal burden, disease recurrence, and survival in patients with breast cancer.
This analysis of women with breast cancer in the National Cancer Data Base describes barriers to the use of breast-conserving therapy.
This review reports on the use of breast-specific gamma imaging as an adjunct imaging method for detecting invasive lobular carcinomas.
This study evaluates the safety of not performing a sentinel node biopsy for patients 70 years of age or older with clinically node-negative breast cancer.
This prospective feasibility trial adds selective removal of clip-containing lymph nodes to sentinel lymph node dissection, with the possibility of identifying patients for limited nodal surgery after chemotherapy.
This retrospective study demonstrates trends toward higher proportions of breast conservation surgery–eligible patients undergoing mastectomy, breast reconstruction, and bilateral mastectomy in the past decade. See also the Invited Commentary by Sun and Zenilman.
This retrospective database review reports that the risk of metachronous breast cancer is low in patients with known BRCA mutations and epithelial ovarian cancer. A majority of these cases of breast cancer at an early stage are detected by use of mammography.
This database analysis found that approximately one-fourth of patients undergoing initial breast conservation surgery for breast cancer will have a subsequent operative intervention. See also the Invited Commentary by Margenthaler and Vaughan.
Morrow et al examine correlates of reconstruction and determine if a significant unmet need for reconstruction exists among women with breast cancer who undergo mastectomy.
Black et al determine racial differences in the use of sentinel lymph node biopsy among patients with pathologically node-negative breast cancer during the period when sentinel lymph node biopsy became the preferred method for axillary staging as well as whether such differences affect lymphedema risk. See the Invited Commentary by Murphy and Schulick.
Hawley and colleagues determine factors associated with the use of contralateral prophylactic mastectomy in a population-based sample of patients with breast cancer. Rosenberg and Partridge provide discussion in a related Invited Commentary.
Agarwal and coauthors compare the breast cancer–specific survival rates of a contemporary cohort of female patients with early-stage invasive ductal carcinoma undergoing breast conservation therapy, mastectomy alone, or mastectomy with radiation.
Yen et al evaluate measures of surgical expertise, including the percentage of a surgeon’s operations for breast cancer, on the use of sentinel lymph node biopsy for invasive breast cancer. Zenilman provides an invited commentary.
Bagaria et al use as an example the triple-negative phenotype defined by the absence of estrogen
receptor, progesterone receptor, and human epidermal growth factor 2 to examine whether such
inclusion improves the prognostic accuracy of TNM staging for breast cancer.